Allergy/Immunology · Lincoln, NE
NPI
1144282096
Since 2006
Specialty
Allergy/Immunology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
600 N Cotner Blvd, Suite 208
Lincoln, NE, 68505
Phone (402) 464-5969
Groups this clinician bills Medicare through
Medicare paid, 2024
$170K
8,359 services
Medicare patients, 2024
340
Average age 73
Drug cost, 2024
$272K
1,597 prescriptions
Company payments, 2025
$842
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Sullivan III was code J2357 (injection, omalizumab, 5 mg), 2,355 times for 18 patients. In total Michael J Sullivan III billed 8,359 services in 29 codes, and Medicare paid $170K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 2,355 | 18 | $29.93 | $70K |
| J2182 Injection, mepolizumab, 1 mg | Office | 1,900 | 11 | $23.80 | $45K |
| 95004 Test - Miscellaneous | Office | 1,604 | 33 | $2.14 | $3,430 |
| 95117 Treatment - Miscellaneous | Office | 192 | 77 | $7.19 | $1,380 |
| 95165 Treatment - Miscellaneous | Office | 180 | 25 | $9.71 | $1,747 |
| 99213 Office E&M - Established | Office | 151 | 115 | $57.48 | $8,679 |
| 95115 Treatment - Miscellaneous | Office | 116 | 47 | $5.69 | $660 |
| 96372 Injection Administration | Office | 103 | 35 | $9.96 | $1,026 |
| 99203 Office E&M - New | Office | 34 | 34 | $71.50 | $2,431 |
| 99213 Office E&M - Established | Facility | 20 | 18 | $31.70 | $634 |
| 94010 Pulmonary Function Testing | Office | 20 | 19 | $17.45 | $349 |
| 99204 Office E&M - New | Office | 16 | 16 | $119.43 | $1,911 |
| 95012 Pulmonary | Office | 11 | 11 | $12.25 | $135 |
By year: 2022 $96K for 4,820 services; 2023 $129K for 5,580 services; 2024 $170K for 8,359 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Sullivan III prescribed most often to Medicare patients was Montelukast Sodium, with 303 prescriptions and refills. In total Michael J Sullivan III wrote 1,597 Medicare prescriptions that cost $272K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 303 | 620 | 72 | $2,681 |
| Azelastine Hcl Generic | 127 | 171 | 33 | $3,360 |
| Fluticasone Propionate Generic | 94 | 131 | 23 | $1,511 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 90 | 104 | 37 | $2,190 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 78 | 95 | 14 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 72 | 80 | 14 | $18K |
| Zafirlukast Generic | 57 | 78 | 12 | $3,746 |
| Breo Ellipta Fluticasone/Vilanterol | 44 | 50 | Under 11 | $20K |
| Spiriva Respimat Tiotropium Bromide | 43 | 49 | Under 11 | $25K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 39 | 45 | Under 11 | $29K |
| Levocetirizine Dihydrochloride Generic | 37 | 57 | Under 11 | $301 |
| Advair Hfa Fluticasone Propion/Salmeterol | 32 | 36 | Under 11 | $12K |
| Arnuity Ellipta Fluticasone Furoate | 31 | 39 | Under 11 | $9,890 |
| Prednisone Generic | 29 | 29 | 22 | $59.37 |
| Ipratropium Bromide Generic | 28 | 34 | Under 11 | $950 |
Brand drugs: - claims; generic drugs: 959 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Sullivan III $842 ($842 in general payments such as food, travel and fees) from 8 companies. The largest payer was Consortium of Independent Immunology Clinics, LLC with $476.
| Company | Payments | Amount |
|---|---|---|
| Consortium of Independent Immunology Clinics, LLC | 1 | $476 |
| Genzyme Corporation SNY | 11 | $239 |
| Hospira, Inc. PFE | 2 | $30.75 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $24.1 |
| TerSera Therapeutics LLC | 1 | $23.1 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $19.2 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.25 |
| GlaxoSmithKline, LLC. GSK | 1 | $13.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.